Pomerantz Law Firm Probes Allegations Against Vanda Pharmaceuticals for Securities Fraud Pomerantz LLP is investigating potential securities fraud claims against Vanda Pharmaceuticals Inc. following an FDA setback regarding HETLIOZ.

Pomerantz Law Firm Probes Allegations Against Vanda Pharmaceuticals for Securities Fraud #None #Pomerantz_LLP #Vanda_Pharmaceuticals #Hetlioz

FDA turns down Hetlioz for jet lag once again Vanda will continue to push for approval of Hetlioz for jet lag, despite the FDA saying its trial designs were not satisfactory.

#VandaPharma may have forced the #FDA to revisit its marketing application for #Hetlioz as a therapy for #jetlag, but the outcome has remained the same.

pharmaphorum.com/news/fda-tur...

Vanda Pharmaceuticals Faces FDA Setback on HETLIOZ® for Jet Lag Disorder Approval Vanda Pharmaceuticals has received a decision letter from the FDA indicating that the supplemental New Drug Application for HETLIOZ® for jet lag disorder cannot be approved in its current form, citing inadequate evidence of efficacy.

Vanda Pharmaceuticals Faces FDA Setback on HETLIOZ® for Jet Lag Disorder Approval #United_States #Washington #Vanda_Pharmaceuticals #Hetlioz #Jet_Lag_Disorder

Vanda Pharmaceuticals Partners with FDA to Resolve Disputes on Drug Approvals Vanda Pharmaceuticals Inc. has established a collaborative framework with the FDA to settle disputes regarding HETLIOZ and tradipitant. This partnership aims for expedited reviews and clearer pathways for drug approval.

Vanda Pharmaceuticals Partners with FDA to Resolve Disputes on Drug Approvals #United_States #Washington_D.C. #Vanda_Pharmaceuticals #Hetlioz #Tradipitant

Vanda Pharmaceuticals Urges FDA Review on Generics Approval Decision for Hetlioz® Vanda Pharmaceuticals is seeking an FDA review regarding the approval of generic versions of Hetlioz®, citing serious concerns over the decision-making process.

Vanda Pharmaceuticals Urges FDA Review on Generics Approval Decision for Hetlioz® #USA #Washington #Vanda_Pharmaceuticals #Hetlioz #FDA_Review

Vanda Pharmaceuticals Scores Significant Legal Victory Against FDA for Jet Lag Drug Approval In a landmark decision, Vanda Pharmaceuticals has successfully overturned the FDA's denial of Hetlioz for jet lag treatment, marking a pivotal moment for travelers.

Vanda Pharmaceuticals Scores Significant Legal Victory Against FDA for Jet Lag Drug Approval #United_States #Washington #Vanda_Pharmaceuticals #Hetlioz #Jet_Lag

Vanda Pharmaceuticals Achieves Notable Growth in 2024: Revenue Highlights and Future Prospects Vanda Pharmaceuticals reports significant revenue growth for 2024, fueled by increasing sales of Fanapt, Hetlioz, and new product launches. Explore the company's future projections and developments in psychiatry and immunology.

Vanda Pharmaceuticals Achieves Notable Growth in 2024: Revenue Highlights and Future Prospects #United_States #Washington #Vanda_Pharmaceuticals #Fanapt #Hetlioz

Vanda Expands Efforts to Pull Two Hetlioz Copies From US Shelves Vanda Pharmaceuticals Inc. expanded its efforts to get Apotex Inc. and Teva Pharmaceuticals Industries Ltd.’s generic versions of its Hetlioz sleep-disorder drug pulled from US shelves, alleging in tw...

"Vanda Pharmaceuticals Inc. expanded its efforts to get Apotex Inc. and Teva Pharmaceuticals Industries Ltd.’s generic versions of its Hetlioz sleep-disorder drug pulled from US shelves..." Paywall, couldn't read the whole thing.
#Non24 #Hetlioz #Teva #Apotex
news.bloomberglaw.com/ip-law/vanda...